Bionano Genomics, Inc. Other Accrued Liabilities, Current
Bionano Genomics, Inc. (BNGO) had Other Accrued Liabilities, Current of $416.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2026-08-10
- 2026-06-30: Other Accrued Liabilities, Current $416.00K.
- 2026-03-31: Other Accrued Liabilities, Current $458.00K.
- 2025-12-31: Other Accrued Liabilities, Current $499.00K.
- 2025-09-30: Other Accrued Liabilities, Current $73.00K.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $416.00K 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $458.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $499.00K 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $73.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $85.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $140.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $634.00K 10-K · filed 2026-03-23 | |
| 2024-09-30 | $75.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $255.00K 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $400.00K 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $515.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $517.00K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $417.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $849.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $1.15M 10-K · filed 2024-03-05 | |
| 2022-09-30 | $827.00K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $154.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $1.31M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $1.11M 10-K · filed 2023-03-09 | $1.94M 10-K · filed 2022-03-01 |
| 2020-12-31 | $403.00K 10-K · filed 2022-03-01 | $515.87K 10-K · filed 2021-03-23 |
| 2019-12-31 | $354.69K 10-K · filed 2021-03-23 | $435.30K 10-K · filed 2020-03-10 |
| 2019-09-30 | $1.18M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $1.00M 10-Q · filed 2019-08-08 | |
| 2018-12-31 | $469.63K 10-K · filed 2020-03-10 | $871.64K 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |